CIM: What disadvantages do you have with your competitors and how do you plan on resolving those disadvantages?
NextRX: They are well funded and established. We are a startup armed with a big vision that’s looking to deliver a big bang.
CIM: Is your platform proprietary or patented?
NextRX: Proprietary.
CIM: Explain your revenue model? How do you make money?
NextRX: Dispensaries buy RXChange with a 3% fee. That will be our primary source of revenue.
CIM: What are your major hurdles and obstacles?
NextRX: Funding and team and system development.
CIM: How would you advertise and roll your platform out to dispensaries?
NextRX: Major marketing campaigns through all available channels and maybe free new equipment for the first 50 dispensaries that sign up.
CIM: What previous experience does management have to assist NextRx in executing on its business plan strategy?
NextRX: Ralf is a serial entrepreneur who has founded 12 startups and (www.iapprentice.com) Most of his companies were in the customized watch industry where he became very familiar with all aspects of running companies.
CIM: How does marijuana legislation impact your business?
NextRX: The train has left the station on the state level. It’s only a matter of time until the feds follow.
203